CT texture analysis can be a potential tool to differentiate gastrointestinal stromal tumors without KIT exon 11 mutation

被引:36
|
作者
Xu, Fei [1 ,2 ]
Ma, Xiaohong [1 ,2 ]
Wang, Yichen [1 ,2 ]
Tian, Yuan [1 ,2 ]
Tang, Wei [1 ,2 ]
Wang, Meng [2 ,3 ]
Wei, Ren [4 ]
Zhao, Xinming [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Dept Imaging Diag, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
[2] Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
[3] Chinese Acad Med Sci, Dept Epidemiol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
[4] Capital Med Univ, Beijing Tiantan Hosp, Dept Radiol, 6 Tiantan Xili, Beijing 100050, Peoples R China
关键词
Gastrointestinal stromal tumor; CT; Texture analysis; KIT mutation; PDGFRA MUTATIONS; CELL CARCINOMA; SARCOMA-GROUP; LUNG-CANCER; IMATINIB; PREDICTION; SURVIVAL; THERAPY; TRIAL; LEIOMYOSARCOMAS;
D O I
10.1016/j.ejrad.2018.07.025
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To evaluate CT texture analysis as a tool to differentiate gastrointestinal stromal tumors (GISTs) without KIT exon 11 mutation. Materials and methods: This study consisted of a study group of 69 GISTs and a validation group of 17 GISTs. Clinical information of the patients were collected and analyzed. Two-dimensional and three-dimensional texture analysis was performed. The textural parameters were evaluated in the study group and were validated in the validation group. The repeatability of the textural parameters on the single region of interest (single-ROI), double-ROI, and whole volume of interest (whole-VOI) was analyzed. The independent predictor for the GIST genotypes was analyzed with logistic regression models. The support vector machine (SVM) classifiers were also trained and 6-fold cross validation ROC curves were computed. Subjective heterogeneity scores of each lesion on enhanced CT images were given by radiologists and the corresponding difference of the heterogeneity rating was evaluated. Results: The non-gastric location, lower CD34_stain level and higher textural parameter standard Deviation (stdDeviation) were associated with the GISTs without KIT exon 11 mutation in the study group. The cross validation SVM classifiers achieved with combination of stdDeviation, anatomic location and CD34_stain level demonstrated medium to good prediction efficiency (AUC = 0.864-0.904) regarding the GIST genotypes. The stdDeviation was an independent predictor of GISTs without KIT exon 11 mutation, and had a medium correlation with the GIST genotypes in the study group (AUC = 0.726-0.750). The stdDeviation showed good performance (AUC = 0.904-0.962) when validated in the validation group. The double-ROIs improved the performances of single-ROIs, decreasing the variances of single-ROIs brought by section-selection, and demonstrating excellent agreements between ROIs and whole-VOI. Subjective heterogeneity scores had no statistically significant differences between GIST genotypes. Conclusion: CT texture analysis can potentially help to differentiate GISTs without KIT exon 11 mutation from those GISTs with KIT exon 11 mutation on enhanced CT images.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 50 条
  • [21] Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11
    Emmalena Gregory-Bryson
    Elizabeth Bartlett
    Matti Kiupel
    Schantel Hayes
    Vilma Yuzbasiyan-Gurkan
    BMC Cancer, 10
  • [22] Analysis of mutation of the c-Kit gene and PDGFRA in gastrointestinal stromal tumors
    Xu, Chun-Wei
    Lin, Shan
    Wang, Wu-Long
    Gao, Wen-Bin
    Lv, Jin-Yan
    Gao, Jing-Shan
    Zhang, Li-Ying
    Li, Yang
    Wang, Lin
    Zhang, Yu-Ping
    Tian, Yu-Wang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (03) : 1045 - 1051
  • [23] Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior:: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors
    Antonescu, CR
    Sommer, G
    Sarran, L
    Tschernyavsky, SJ
    Riedel, E
    Woodruff, JM
    Robson, M
    Maki, R
    Brennan, MF
    Ladanyi, M
    DeMatteo, RP
    Besmer, P
    CLINICAL CANCER RESEARCH, 2003, 9 (09) : 3329 - 3337
  • [24] c-kit gene mutation at exon 17 or 13 is very rare in sporadic gastrointestinal stromal tumors
    Kinoshita, K
    Isozaki, K
    Hirota, S
    Nishida, T
    Chen, H
    Nakahara, M
    Nagasawa, Y
    Ohashi, A
    Shinomura, Y
    Kitamura, Y
    Matsuzawa, Y
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (02) : 147 - 151
  • [25] Value of contrast-enhanced CT based radiomic machine learning algorithm in differentiating gastrointestinal stromal tumors with KIT exon 11 mutation: a two-center study
    Liu, Bo
    Liu, Hao
    Zhang, Lequan
    Song, Yancheng
    Yang, Shifeng
    Zheng, Ziwen
    Zhao, Junjiang
    Hou, Feng
    Zhang, Jian
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2022, 28 (01) : 29 - 38
  • [26] Effect of Imatinib Mesylate in a Patient with a Metastatic Gastrointestinal Stromal Tumor with a c-kit Mutation in Exon 11
    Keisuke Kubota
    Atom Katayama
    Yutarou Takeshita
    Koji Nozaki
    Tetsuya Ueda
    Kazuhiro Imamura
    Naoki Hiki
    Sachiyo Nomura
    Michio Kaminishi
    Ken-Ichi Mafune
    Digestive Diseases and Sciences, 2007, 52 : 1725 - 1729
  • [27] Effect of imatinib mesylate in a patient with a metastatic gastrointestinal stromal tumor with a c-kit mutation in exon 11
    Kubota, Keisuke
    Katayama, Atom
    Takeshita, Yutarou
    Nozaki, Koji
    Ueda, Tetsuya
    Imamura, Kazuhiro
    Hiki, Naoki
    Nomura, Sachiyo
    Kaminishi, Michio
    Mafune, Ken-Ichi
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (07) : 1725 - 1729
  • [28] Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors
    Lasota, Jerzy
    Dobosz, Anna Jerzak Vel
    Wasag, Bartosz
    Wozniak, Agnieszka
    Kraszewska, Ewa
    Michej, Wanda
    Ptaszynski, Konrad
    Rutkowski, Piotr
    Sarlomo-Rikala, Maarit
    Steigen, Sonja E.
    Schneider-Stock, Regine
    Stachura, Jerzy
    Chosia, Maria
    Ogun, Gabriel
    Ruka, Wlodzimierz
    Siedlecki, Janusz A.
    Miettinen, Markku
    LABORATORY INVESTIGATION, 2007, 87 (10) : 1029 - 1041
  • [29] Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors
    Shen, Yan-Ying
    Ma, Xin-Li
    Wang, Ming
    Zhuang, Chun
    Ni, Bo
    Tu, Lin
    Liu, Qiang
    Zhao, Wen-Yi
    Cao, Hui
    CANCER MEDICINE, 2020, 9 (18): : 6485 - 6496
  • [30] A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors
    Jiang, Zhiqiang
    Zhang, Jian
    Li, Zhi
    Liu, Yingjun
    Wang, Daohai
    Han, Guangsen
    ONCOTARGETS AND THERAPY, 2016, 9 : 3387 - 3397